UBS upgraded AstraZeneca from 'neutral' to 'buy' on Thursday, citing the pharmaceutical firm's "sector-leading" drug pipeline.
Analysts at Berenberg slightly lowered their target price on gold producer Pan African Resources from 42. 0p to 39. 0p on Thursday as they rebased their stance on the stock following the publication of its H1 numbers.
UBS has upgraded AstraZeneca to a ‘buy’, citing the London-listed pharmaceutical firm’s "sector-leading" drug pipeline.
Morgan Stanley has initiated coverage of pharma giant AstraZeneca with an 'overweight' rating and 14,5000p target price, recommending investors to build positions at a "compelling entry point".
Analysts at Berenberg lowered their target price on finance business S&U from 2,100. 0p to 1,700. 0p on Wednesday but noted that the group was continuing to navigate a "challenging environment".
The surprise retirement of Dunelm's boss shouldn't put off investors from the homeware retailer's strong growth prospects, according to Canaccord Genuity which reiterated its 'buy' rating on the stock.
Citi upped its price target on Smiths Group on Wednesday to 2,700p from 2,400p as it updated its break-up analysis.
Morgan Stanley has initiated coverage of pharma giant AstraZeneca with an 'overweight' rating, recommending investors to build positions at a "compelling entry point".
Berenberg slightly raised its target price on bookmaker Entain from 1,010. 0p to 1,035. 0p on Tuesday, stating it was "continuing to bet" on the BetMGM turnaround.
Analysts at Canaccord Genuity slightly raised their target price on Celtic from 202. 0p to 208. 0p on Tuesday, stating the firm's improved UCL campaign drives FY25 upgrades.
Analysts at Berenberg slightly raised their target price on bookmaker Entain from 1,010. 0p to 1,035. 0p on Tuesday, stating it was "continuing to bet" on the BetMGM turnaround.
JPMorgan Cazenove upgraded Spectris on Monday to 'overweight' from 'neutral' and hiked the price target to 3,450. 0p from 2,650. 0p.
Analysts at Berenberg slightly raised their target price on cosmetics firm Warpaint London from 680. 0p to 700. 0p on Monday, noting the group's margin management was not to be overlooked.
JPMorgan Cazenove upgraded Spectris on Monday to ‘overweight’ from ‘neutral’ and hiked the price target to 3,450p from 2,650p.
Deutsche Bank downgraded Fever-Tree Drinks on Monday to ‘hold’ from ‘buy’ and slashed the price target to 800p from 1,325p as it said the deal with Molson Coors "lacks near-term fizz".
Berenberg has reiterated its 'buy' rating for Currys after the electrical retailer became the first-ever Xbox Authorised Service Provider in the UK & Ireland, saying the deal is "much more than meets the eye".
Barclays upgraded IWG on Friday to ‘overweight’ from ‘equalweight’ and hiked the price target to 260p from 161p as it said the shares are "ripe for a re-rating".
RBC Capital Markets has cut its target price for Anglo American from 2,200p to 2,130p and kept an 'underperform' stance on the stock after downgrading its profit forecasts for the next three years.
Analysts at Berenberg reiterated its 'buy' rating on retailer Next in view of "some interesting medium-term growth angles".
A huge decline in the share price of Ricardo has prompted Shore Capital to upgrade its rating on the environmental and engineering consultancy from 'sell' to 'hold'.